Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Suspended × NSCLC × Clear all

Phase

Status

Unknown 3 Completed 3 Recruiting 2 Withdrawn 1 Terminated 1 Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 3 Triple Negative Breast Neoplasms 2 Prostatic Neoplasms 2 Neoplasms 2 Leukemia 2 Colorectal Neoplasms 2 Uterine Cervical Neoplasms 1 Radiation Injuries 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Pain, Intractable 1 Ovarian Neoplasms 1 Neurotoxicity Syndromes 1 Neoplasm Metastasis 1 NSCLC 1 Multiple Myeloma 1 Mucositis 1 Malnutrition 1 Malignant Female Reproductive System Neoplasm 1 Lung Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Glioblastoma 1 Fatigue 1 Fasting Mimicking Diet 1 Depressive Disorder, Major 1 Carcinoma, Hepatocellular 1 Cachexia 1 Burkitt Lymphoma 1 Breast Carcinoma In Situ 1

Interventions

HM781-36B 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05378763 2026-02-18

PINNACLE

Spectrum Pharmaceuticals, Inc

Phase 3 Suspended

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡